Administration and dosage: The drug OTC is administered perorally according to the following schedule:
First 3 days: 1 tablet 6 times daily (every 2 hours) with a parallel reduction of the number of cigarettes smoked.
4th to 12th day: 1 tablet every 2 1/2 hours (5 tablets daily)
13th to 16th day: 1 tablet every 3 hours (4 tablets daily)
17th to 20th day: 1 tablet every 5 hours (3 tablets daily)
21st to 25th day: 1 to 2 tablets daily
Smoking cessation should occur by the 5th day after the initiation of the treatment. After the end of the therapeutic course, in order to have good results, the patient should give evidence of strong will, not allowing the lighting of a cigarette.
If the result is unsatisfactory, the treatment is discontinued and a new therapy can be resumed after 2-3 months.
Undesired adverse effects:
The clinical studies showed a good tolerance to the drug and grave adverse effects were not observed.
The following adverse effects are rather often observed at the beginning of Tabex and Desmoxan treatment: changes in both taste and appetite, dryness in the mouth, headache, irritability, nausea, constipation, tachycardia, light elevation of the arterial pressure. The majority of the adverse effects can abate in the course of the treatment.
The filmtablets Tabex and Desmoxan are packed in PVC/aluminum foil blister strips. Each blister strip contains 20 filmtablets. Five blister strips are packed in a cardboard box together with package insert.
Storage: In original packages, in dry, and light-protected premises at temperature of 15° -25° C (60° – 75° F)
Expiry term: Two year from manufacture date. /2019
How dispensed: No physician prescription required